{
    "medicine_id": "41a6c922d5bc205806fccef9b145951c6ac707f4",
    "platform_id": "DB00523",
    "metadata": {
        "name": "Clindamycin 1 Niacinamide 4 Tretinoin 0 05 10 mg Capsule",
        "composition": "10 mg Alitretinoin",
        "clinical_particulars": {
            "therapeutic_indications": "For topical treatment of cutaneous lesions in patients with AIDS related Kaposi s sarcoma",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Alitretinoin 9 i cis i retinoic acid is a naturally occurring endogenous retinoid indicated for topical treatment of cutaneous lesions in patients with AIDS related Kaposi s sarcoma Alitretinoin inhibits the growth of Kaposi s sarcoma KS cells i in vitro i",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00012",
                        "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB00016",
                        "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The risk or severity of Thrombosis can be increased when Peginesatide is combined with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB01083",
                        "description": "Orlistat can cause a decrease in the absorption of Alitretinoin resulting in a reduced serum concentration and potentially a decrease in efficacy"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "Alitretinoin may increase the hepatotoxic activities of Methotrexate"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "The therapeutic efficacy of Diethylstilbestrol can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "The therapeutic efficacy of Estradiol can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "The therapeutic efficacy of Ethinylestradiol can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB01357",
                        "description": "The therapeutic efficacy of Mestranol can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "The therapeutic efficacy of Estradiol cypionate can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "The therapeutic efficacy of Estradiol valerate can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB00304",
                        "description": "The therapeutic efficacy of Desogestrel can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB00351",
                        "description": "The therapeutic efficacy of Megestrol acetate can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB00367",
                        "description": "The therapeutic efficacy of Levonorgestrel can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB00603",
                        "description": "The therapeutic efficacy of Medroxyprogesterone acetate can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB00717",
                        "description": "The therapeutic efficacy of Norethisterone can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB00823",
                        "description": "The therapeutic efficacy of Ethynodiol diacetate can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB00957",
                        "description": "The therapeutic efficacy of Norgestimate can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB01395",
                        "description": "The therapeutic efficacy of Drospirenone can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB04839",
                        "description": "The therapeutic efficacy of Cyproterone acetate can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB06730",
                        "description": "The therapeutic efficacy of Gestodene can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB06789",
                        "description": "The therapeutic efficacy of Hydroxyprogesterone caproate can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB09123",
                        "description": "The therapeutic efficacy of Dienogest can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB09371",
                        "description": "The therapeutic efficacy of Norethynodrel can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB09389",
                        "description": "The therapeutic efficacy of Norgestrel can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB11619",
                        "description": "The therapeutic efficacy of Gestrinone can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB12474",
                        "description": "The therapeutic efficacy of Lynestrenol can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB13528",
                        "description": "The therapeutic efficacy of Chlormadinone can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB13563",
                        "description": "The therapeutic efficacy of Norgestrienone can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB13685",
                        "description": "The therapeutic efficacy of Quingestanol can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB13857",
                        "description": "The therapeutic efficacy of Demegestone can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB13981",
                        "description": "The therapeutic efficacy of Nomegestrol acetate can be decreased when used in combination with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB00162",
                        "description": "The risk or severity of adverse effects can be increased when Vitamin A is combined with Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB00313",
                        "description": "Valproic acid may increase the Pseudotumor Cerebri activities of Alitretinoin"
                    },
                    {
                        "drugbank-id": "DB00254",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Alitretinoin is combined with Doxycycline"
                    },
                    {
                        "drugbank-id": "DB00453",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Alitretinoin is combined with Clomocycline"
                    },
                    {
                        "drugbank-id": "DB00560",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Alitretinoin is combined with Tigecycline"
                    },
                    {
                        "drugbank-id": "DB00595",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Alitretinoin is combined with Oxytetracycline"
                    },
                    {
                        "drugbank-id": "DB00618",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Alitretinoin is combined with Demeclocycline"
                    },
                    {
                        "drugbank-id": "DB00759",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Alitretinoin is combined with Tetracycline"
                    },
                    {
                        "drugbank-id": "DB00931",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Alitretinoin is combined with Metacycline"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Alitretinoin is combined with Minocycline"
                    },
                    {
                        "drugbank-id": "DB01301",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Alitretinoin is combined with Rolitetracycline"
                    },
                    {
                        "drugbank-id": "DB12035",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Alitretinoin is combined with Sarecycline"
                    },
                    {
                        "drugbank-id": "DB12329",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Alitretinoin is combined with Eravacycline"
                    },
                    {
                        "drugbank-id": "DB12455",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Alitretinoin is combined with Omadacycline"
                    },
                    {
                        "drugbank-id": "DB13264",
                        "description": "The risk or severity of pseudotumor cerebri and elevated intracranial pressure can be increased when Alitretinoin is combined with Penimepicycline"
                    },
                    {
                        "drugbank-id": "DB00256",
                        "description": "The risk or severity of pseudotumor cerebri can be increased when Alitretinoin is combined with Lymecycline"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}